Episode 15 of ON AIR with EUFOREA brings together Professor Wytske Fokkens and Professor Peter Hellings for an expert discussion on the position of sinus surgery in relation to biologics, as debated during a recent consensus meeting.
In this episode, the speakers explore how surgical interventions and biologic therapies can be positioned within modern treatment pathways for chronic rhinosinusitis and related airway diseases. They reflect on evolving clinical evidence, current practice patterns, and the considerations that guide decision-making when integrating surgery and biologics in patient care.
The conversation highlights areas of agreement and ongoing debate, emphasizing the importance of individualized treatment strategies, multidisciplinary collaboration, and clear clinical criteria to optimize outcomes. Professors Fokkens and Hellings also share insights from the consensus process, offering valuable context for clinicians navigating these complex therapeutic choices.
Listeners will gain a clearer understanding of how sinus surgery and biologics can complement each other, the challenges clinicians face when sequencing or combining treatments, and how consensus-driven guidance can support more consistent, evidence-based care.
Tune in to explore how expert alignment and integrated approaches are shaping the future of ENT and airway disease management.
Watch the episode
Listen on Spotify
Listen to other episodes
You might also be interested by:
-

Episode #15: Discussing the position of sinus surgery in relation to biologics
Episode 15 of ON AIR with EUFOREA brings together Professor Wytske Fokkens and Professor Peter Hellings for an expert discussion on the position of sinus surgery in relation to biologics,…
-

How can we use biologics and surgery to get the best outcomes for patients with CRSwNP?
The management of patients with Chronic Rhinosinusitis with Nasal Polyps (or CRSwNP) has been subject to a major revolution of care, considering the improved knowledge of the underlying pathology over…
-

Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) – What’s in a name?
#LetsTalkCRS In 2022 EUFOREA launched its first Global Rhinosinusitis with Nasal Polyps Awareness Day, as part of a broader strategy to raise awareness of this debilitating and often underdiagnosed disease…
